This article has been updated with information and comments from Foundation Medicine's earnings call.

NEW YORK (GenomeWeb) – Foundation Medicine reported a 39 percent increase in fourth quarter revenues after the close of market on Tuesday, driven by strong growth from its pharmaceutical business.

The Cambridge, Massachusetts-based firm booked $26.1 million in fourth quarter revenues, up from $18.7 million a year ago, and narrowly beating the consensus Wall Street estimate of $25.8 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.